Alternative splicing is known to generate multiple functionally distinct calcium channel variants that exhibit unique spatial and temporal expression patterns. In humans, naturally occurring mutations in genes encoding calcium channel pore forming α 1 -subunits are associated with several severe hereditary disorders although it remains to be described whether there exists any relationship between the physiological effects of these mutations and calcium channel splice variation. In the present study, we systematically compare the biophysical effects of three type-1 familial hemiplegic migraine (FHM-1) mutations in two predominant splice variants of the neuronal Ca V 2.1 P/Q-type channel. All three FHM-1 mutations cause a greater hyperpolarizing shift in voltage-dependent properties when expressed in the short carboxyl terminus variant (Ca V 2.1 Δ47) compared to the long variant (Ca V 2.1 +47). Furthermore, the FHM-1 mutations also exhibit differential splice variant-specific effects on recovery from inactivation and accumulation of inactivation during tonic and burst firing. Our findings provide important insight concerning the role of calcium channel alternatively spliced variants and the molecular pathophysiology of FHM-1 and potentially of other calcium channelopathies.
Introduction
Voltage-gated calcium channels are important in many normal physiological processes including muscle contraction, neurotransmitter release, regulation of calcium-dependent enzymes and gene expression (reviewed in ref. 1) . It is therefore perhaps not surprising that naturally occurring mutations in calcium channel genes have been implicated in a number of severe human diseases. Since the first mutation in a calcium channel was identified, 2,3 over 150 individual mutations have now been reported in five of the ten genes encoding calcium channel pore forming α 1 -subunits (Ca V ) and are associated with nine distinguishable disorders ("calcium channelopathies"). Over the past decade studies using recombinant channels in various expression systems have shown that many of these mutations have significant positive or negative effects on channel gating and/or expression levels, while others result in nonfunctional channels or have dominant negative effects (reviewed in ref. 4) . It is noteworthy that the effects of mutations on channel function have thus far only been tested in a small subset of known calcium channel variants and a direct comparison of how mutations affect channel alternative splice variants has been largely unexplored.
It has been predicted that the ten genes encoding Ca V subunits have the potential to generate thousands of functionally distinct splice variants. 5, 6 Indeed, isolation and characterization of some variants has shown that alternative splicing can be a means to obtain specialized calcium channel function and to optimize calcium signalling regionally, temporally and under altered environmental conditions (reviewed in refs. [6] [7] [8] . It is evident that mutations directly at a splice-site or in an alternate exon can have effects on pre-mRNA splicing and/or affect a subset of splice variants expressing alternate exons. [9] [10] [11] [12] However, the majority of identified mutations associated with calcium channelopathies are missense mutations in coding sequences other than splice-sites and alternate exons (reviewed in ref. 4) . Whether channel splice variants have different functional responses to disease-causing missense mutations has not been directly explored. We hypothesized that point mutations associated with calcium channelopathies might have splice-variant specific effects with important implications for both understanding disease pathophysiology and also towards interpreting results obtained from heterologous studies using recombinant channels.
Familial Hemiplegic Migraine (FHM) is an autosomal dominant subtype of migraine characterized by an aura of hemiplegia that is associated with at least one other aura symptom such as hemianopsia, hemisensory deficit or aphasia. 13, 14 Approximately 20 missense mutations associated with FHM have been identified in the CACNA1A gene 15 (called FHM-1) which encodes the α 1 subunit (Ca V 2.1; α 1A ) of the P/Q-type voltage-gated calcium channel. P/Q-type calcium channels are abundantly expressed throughout mammalian brain and spinal cord where they mediate calcium influx essential for neurotransmitter release, calciummediated second messenger signalling and calcium-dependent gene transcription. [16] [17] [18] [19] [20] The functional consequences of FHM-1 mutations on Ca V 2.1 P/Q-type channel properties have been investigated in heterologous Xenopus oocyte and mammalian expression systems, and more recently in neurons and whole brains of FHM-1 mutant R192Q and S218L knock-in mice. [21] [22] [23] [24] [25] [26] [27] [28] While there have been some noted discrepancies reported, in both heterologous and knock-in mice systems there is a general demonstrated trend for FHM-1 mutations to exhibit gain-of-function properties: increased channel availability and increased calcium influx at lower membrane potentials resulting in a greater susceptibility to the cortical spreading depression (CSD) thought to be the underlying mechanism of aura. 21, 22, 27, [29] [30] [31] There are seven identified alternatively spliced sites within the Ca V 2.1 subunit gene and the various splice variants exhibit distinct biophysical characteristics, calcium-dependent properties, pharmacological sensitivities and subtype-specific temporal and regional localizations in human brain. 16, [32] [33] [34] [35] However, it is not known whether the functional impact of FHM-1 mutations is similar amongst the different Ca V 2.1 splice variants or whether alternative splicing contributes to the spatial and temporal nature of the FHM-1 phenotype. The carboxyl terminus of Ca V 2.1 channels is known to affect several physiological processes and alternative splicing in this region confers functional changes in channel properties. 16, 32, [35] [36] [37] [38] The most substantial changes induced by alternative splicing in the C-terminus of Ca V 2.1 channels results from the use of an alternative three prime acceptor site in the intron upstream of the last exon, exon 47. 32, 36, 39, 40 Alternative splicing at exon 47 introduces a frame-shift resulting in a stop codon at the beginning of exon 47. As a result, P/Q-type channels can be of either the short form (isoform 1; Ca V 2.1 (Δ47)) or the long form (isoform 2; Ca V 2.1 (+47)). The voltage-dependent and kinetic properties of the Ca V 2.1 (+47) and Ca V 2.1 (Δ47) splice variants and their relative contributions concerning FHM-1 mutations has not been explored.
In the present study we compared the biophysical properties of wild-type (WT) Ca V 2.1 (+47) and Ca V 2.1 (Δ47) P/Q-type channel splice variants and also explored the effects of three FHM-1 mutations introduced into the two variants. We investigated two mutations, K1336E and R192Q, that are associated with an FHM-1 phenotype of pure hemiplegia and migraine without any other neurological symptoms. 14, 15 We further investigated the S218L FHM-1 mutation which is associated with a severe clinical phenotype wherein typical FHM-1 attacks induced by minor head trauma are often followed by a delayed cerebral edema, fever, stupor and sometimes coma (fatal in one reported instance). [41] [42] [43] We find that the two P/Q-type channel carboxyl tail splice variants exhibit functionally distinct properties and also that the three FHM-1 mutations have differential splice-dependent effects on voltage-dependent and kinetic properties. We discuss the potential importance of the splice-variant differential effects in the context of FHM-1 pathophysiology as well as the implications for other calcium channelopathies.
Results
Ca V 2.1 (+47) and Ca V 2.1 (Δ47) variants are expressed in human cortex. Mutations in the P/Q-type channel Ca V 2.1 subunit underlie FHM-1 and the current consensus is that initiation of migraine attacks is in the cortex, however the expression of splice variants has not yet been described in the human cortex . In order to determine whether the Ca V 2.1 (+47) and Ca V 2.1 (Δ47) variants are expressed in human cortex we utilized RT-PCR to amplify a ~1.1 Kb carboxyl terminal fragment of Ca V 2.1 from adult human cortex RNA using oligonucleotide primers that recognize both carboxyl alternatively spliced variants in a non-biased manner. The PCR products were subsequently re-amplified using splice-variant specific primers. Figure 1 shows that the Ca V 2.1 (+47) and Ca V 2.1 (Δ47) splice variants are both expressed in human cortex. To determine their relative proportions, the human cortical Ca V 2.1 carboxyl terminal PCR products were sub-cloned and individual cDNAs analyzed using splice-variant specific primers and direct DNA sequencing. From the 53 cDNA clones analyzed we determined that the Ca V 2.1 (+47) and Ca V 2.1 (Δ47) splice variants were present in whole cortex in relative proportions of 79% and 21%, respectively.
All subsequent biophysical analyses were performed using human long Ca V 2.1 (+47) and short Ca V 2.1 (Δ47) splice-variant cDNA clones with either WT or FHM-1 mutant K1336E, R192Q or S218L changes introduced (see Fig. 1A for the location of the FHM-1 mutations).
FHM-1 mutations exhibit differential effects on the voltagedependent properties of Ca V 2.1 splice variants. Whole cell current analysis of transiently transfected cells showed that the WT Ca V 2.1 (Δ47) and WT Ca V 2.1 (+47) variants possess similar membrane potentials at which half the channels are activated (V 50act = -14.02 ± 1.49, and -15.08 ± 1.20, respectively) and similar membrane potentials at which half of the channels are inactivated (V 50inact = -58.20 ± 2.04, and -62.07 ± 1.87, respectively; see Table 1 and Fig. 2 ). The K1336E, R192Q and S218L mutations have been previously reported to cause a hyperpolarizing shift in the currentvoltage relationship relative to WT Ca V 2.1 channels. 24, 26, 27, 29, 46 Examining the FHM-1 mutations in the P/Q-type +47 and Δ47 carboxyl tail splice variants we found differential effects. The K1336E Ca V 2.1 (+47) and R192Q Ca V 2.1 (+47) channels both exhibited a small but significant shift in V 50act relative to WT Ca V 2.1 (+47) channels (-21.53 ± 1.35 and -19.11 ± 1.11 vs. -15.08 ± 1.20, respectively; p <0.05; ANOVA), while the S218L mutation had no significant affect on Ca V 2.1 (+47) channels relative to WT (Table 1 and Fig. 2) . In contrast, all three FHM-1 mutations caused large significant hyperpolarizing shifts in V 50act when expressed in Ca v 2.1 (Δ47) variant channels (p < 0.001; ANOVA; Table 1 and Fig. 2 ). Similar differential splice-dependent effects of the FHM-1 mutations were apparent in examining V 50inact . Figure 2 shows that the R192Q and S218L mutations resulted in large (~15-17 mV) hyperpolarizing shifts in V 50inact in the Ca V 2.1 (Δ47) variant relative to WT Ca V 2.1 (Δ47) channels (p < 0.001; ANOVA), while channels (70.4 ± 3.7% and 83.3 ± 2.3% vs. 89.0 ± 1.8 %, respectively; p < 0.05; ANOVA). Contrastingly, K1336E Ca V 2.1 (+47) and R192Q Ca V 2.1 (+47) channels showed increases in recovery relative to WT Ca V 2.1 (+47) channels (86.8 ± 1.7 and 87.0 ± 2.0 vs. 77.3 ± 3.8 %, respectively; p < 0.05; ANOVA) ( Fig. 3 and Table 2 ). The S218L mutation was found to increase the recovery in both splice variants, however, only the S218L Ca V 2.1 (+47) channels showed a significant increase in recovery relative to WT Ca V 2.1 (+47) channels at 7.5 seconds (94.7 ± 1.5 vs. 77.3 ± 3.8 %, respectively; p < 0.001; ANOVA) ( Fig. 3 and Table 2 ).
Overall, in agreement with previous reports, 24, 27 we observed that both the K1336E and S218L mutations can cause significant changes to recovery from inactivation and show for the first time that the R192Q mutation also changes recovery from inactivation. Importantly, we also show that the quantitative effects of the FHM-1 mutations on channel function are dependant upon the nature of the Ca V 2.1 splice variant. We also note that the differential effects of the mutations resulted in significant changes to the functional distinction observed between the two WT channel variants; that is, while the WT Ca V 2.1 (Δ47) channel variant recovered significantly faster than the WT Ca V 2.1 (+47) channel variant, the K1336E Ca V 2.1 (Δ47) channels recovered significantly slower these same two FHM-1 mutations had a smaller effects on Ca V 2.1 (+47) variant channels (p < 0.05; ANOVA; Table 1 ). Interestingly, the K1336E mutation did not cause a significant change in V 50inact in either splice variant. Overall, these data indicate that the impact of individual FHM-1 mutations on P/Q-type channel gating properties is differentially affected by the nature of the splice-variant background in which the mutation is expressed.
FHM-1 mutations exhibit differential effects on recovery from inactivation of Ca V 2.1 splice variants. Analysis of WT Ca V 2.1 (Δ47) and Ca V 2.1 (+47) variants showed different rates of recovery from inactivation for these P/Q-type channel splice variants. WT Ca V 2.1 (Δ47) channels exhibit faster rates of recovery (τ 1 = 0.67 ± 0.11 and τ 2 = 3.08 ± 0.61) than the Ca V 2.1 (+47) variant channels (τ 1 = 0.76 ± 0.21 and τ 2 = 3.39 ± 0.84). As a result, Ca V 2.1 (Δ47) channels show a significantly higher percentage of channels recovered at 7.5 seconds after inactivation relative to Ca V 2.1 (+47) channels (89.0 ± 1.8 vs. 77.3 ± 3.8 %, respectively; p < 0.05; ANOVA) ( Fig. 3 and Table 2 ).
Examining the effects of FHM-1 mutations in the Ca V 2.1 (Δ47) background, Figure 3 shows that the K1336E Ca V 2.1 (Δ47) and R192Q Ca V 2.1 (Δ47) variants exhibit a significant decrease in current recovered at 7.5 seconds relative to WT Ca V 2.1 (Δ47) Figure 1 . Human P/Q-type calcium channel topology and splice-variant expression in human cortex. (A) schematic showing the location of the three FHM-1 mutations and the carboxyl terminal splice site in the human Ca V 2.1 channel. In the box below the channel diagram are partial sequences of the Ca V 2.1 (+47) and Ca V 2.1 (Δ47) variants at the exon 46/exon 47 boundary. The pentanucleotide insertion is shown in bold for the Ca V 2.1 (+47) variant. (B) the last ~1 Kb of the Ca V 2.1 carboxyl terminus was amplified from human cortical RNA and purified. Subsequently, splice-variant specific forward primers (SP) designed to exclusively bind either Ca V 2.1 (Δ47) or Ca V 2.1 (+47) transcripts were used in PCR reactions to generate an ~500 bp fragment from the purified carboxyl fragments; Ca V 2.1 (Δ47)-SP and Ca V 2.1 (+47)-SP, respectively (dotted line is above the sequence that Ca V 2.1 (Δ47)-SP binds and the solid line is above the sequence that Ca V 2.1 (+47)-SP binds in (A). Both splice-variant specific primers generated the expected product from the carboxyl PCR fragment of the Ca V 2.1 cDNA obtained from human cortex, verifying both Ca V 2.1 (Δ47) or Ca V 2.1 (+47) are present in human cortex. Products were verified by direct DNA sequencing and determined to be in relative proportions of 79% Ca V 2.1 (+47) and 21% Ca V 2.1 (Δ47) (bar graph); for protocol details see Materials and Methods. The voltage at which half of the channels are in the activated state (V 50act ) and inactivated state (V 50inact ), and the steepness of the curves for activation (k act ) and inactivation (k inact ) were obtained by fitting the data with the Boltzmann equation for the indicated number of cells in parentheses. The kinetics of activation (τ act )were obtained by fitting the maximum current trace from the IV curves with a single exponential. Asterisks (*) and number signs ( # ) indicate significant difference relative to wild-type with p-values less than either 0.05 or 0.001 (one-way ANOVA), respectively. shows the comparison between current-voltage relationships (IV-curves) for wild-type (WT; black squares), FHM-1 mutant K1336E (KE; grey circles), R192Q (RQ; grey triangles) and S218L (SL; grey diamond) in both the short Ca V 2.1 (Δ47) (filled symbols) and long Ca V 2.1 (+47) (open symbols) C-terminus splice variants. IV curves for all constructs were determined from currents evoked during 90 ms square pulse depolarizations shown between -50 mV and +20 mV from a holding potential of -90 mV. (B) conductance values were calculated from IV curves to obtain activation curves. (C) steady-state inactivation curves were generated using a standard protocol in which 5 s prepulse holdings of -100 to +10 mV were elicited prior to the 80 ms, 0 mV test pulse from a holding of -120 mV. Normalized current evoked during the test pulse is plotted vs. prepulse membrane potential. For complete statistics see Table 1 and for details of protocols see Methods.
of inactivation and thus a lower percent of current remaining at the end of 25 pulses relative to WT Ca V 2.1 (Δ47) and WT Ca V 2.1 (+47) (88.0 ± 2.2% and 84.0 ± 1.7% vs. 95.0 ± 1.4 and 90.0 ± 0.9%, respectively; p < 0.05; ANOVA) (Fig. 4C) . The changes were such that the K1336E Ca V 2.1 (+47) and K1336E Ca V 2.1 (Δ47) variants had similar current remaining at the end of the repetitive stimulation and thus lacked the clear functional distinction observed between the WT channel variants. In the context of the Ca V 2.1 (Δ47) variant background the R192Q mutation caused a significant increase in accumulation of inactivation relative to WT Ca V 2.1 (Δ47) (current remaining at end of the 25 pulses = 90.0 ± 1.6% vs. 95.0 ± 1.4%: p < 0.05; ANOVA). In contrast, R192Q Ca V 2.1 (+47) channels were similar to WT Ca V 2.1 (+47) channels (92 ± 1.3% vs. 90 ± 0.9%) (Fig. 4C ). Similar to K1336E channels, the R192Q Ca V 2.1 (Δ47) and R192Q Ca V 2.1 (+47) channel variants lacked the clear functional distinction observed between the WT variants for this property. than K1336E Ca V 2.1 (+47) channels. In addition, the R192Q and S218L mutations altered recovery such that the R192Q Ca V 2.1 (Δ47) and R192Q Ca V 2.1 (+47) channels and S218L Ca V 2.1 (Δ47) and S218L Ca V 2.1 (+47) channels were not functionally distinct in this parameter ( Fig. 3 and Table 2 ).
FHM-1 mutations exhibit differential effects on inactivation of Ca V 2.1 splice variants during tonic depolarization. WT Ca V 2.1 (+47) and Ca V 2.1 (Δ47) variants exhibit functional differences with regard to accumulation of inactivation during short (3.5 msec) 25 Hz repetitive stimulations (Fig. 4) . While Ca V 2.1 (Δ47) variant channels showed 95.0 ± 1.4% of current remaining at the end of 25 pulses, Ca V 2.1 (+47) variant channels had 90.0 ± 0.9% (p < 0.05; ANOVA) (Fig. 4C) .
All three FHM-1 mutations examined significantly altered accumulation of inactivation (Fig. 4A) ; however, again the effects were contingent on the nature of the Ca V 2.1 variant in which mutations were expressed. The K1336E Ca V 2.1 (Δ47) and K1336E Ca V 2.1 (+47) channels had a significant increase in accumulation Table 2 ). (C) bar graph shows percent recovery at 7.5 seconds for all WT and FHM-1 mutant clones studied. Single asterisks and number signs indicate significant difference between mutant and wild-type of the same variant with p-values less than either 0.05 or 0.001 (one-way ANOVA), respectively. Double asterisks indicate significant difference between the Δ47 and +47 variants containing the same sequence (i.e., WT or mutant) with p-value less than 0.05 (one-way ANOVA). p < 0.05; ANOVA). This may reflect the fact that R192Q Ca V 2.1 (+47) channels exhibit increased recovery from inactivation (see Fig. 3 ). We note that an overall effect concerning current decay during burst firing is for R192Q Ca V 2.1 (+47) channels to behave more similar to that for the WT Δ47 channels and for R192Q Ca V 2.1 (Δ47) channels to behave more similar to those of the WT +47 variant.
Similar to that for the K1336E mutation, the S218L mutation only caused a significant current decay during the burst firing in the Ca V 2.1 (Δ47) variant background (73.0 ± 4.0% vs. 88.0 ± 3.6% current remaining at the end of five bursts, respectively; p < 0.05; ANOVA). Presumably, although the S218L mutation increased accumulation of inactivation substantially in both splice variants (see Fig. 4 ), S218L Ca V 2.1 (+47) channels had a larger increase in the rate of recovery from inactivation (Fig. 3) which likely slowed overall accumulation of inactivation during the burst firing. The S218L Ca V 2.1 (+47) and S218L Ca V 2.1 (Δ47) variants did not differ significantly relative to one another.
Discussion
We report here that FHM-1 missense mutations confer differential effects on the biophysical properties of the Ca V 2.1 (+47) and Ca V 2.1 (Δ47) P/Q-type channel splice variants. Although the current-voltage relationships and steady-state properties of the two WT P/Q-type splice variants are similar, all three
The S218L mutation showed a large and significant increase in accumulation of inactivation and thus a lower percent of current remaining at the end of 25 pulses relative to both the WT Ca V 2.1 (Δ47) and Ca V 2.1 (+47) channel variants (81 ± 2.5% and 77 ± 1.7% vs. 95 ± 1.4 and 90 ± 0.9%, respectively; p < 0.05; ANOVA). Similar to that for R192Q and K1336E, a further overall effect of the S218L mutation is to decrease the relative difference in current remaining observed between WT Ca V 2.1 (Δ47) and Ca V 2.1 (+47) variant channels.
FHM-1 mutations exhibit differential effects on inactivation of Ca V 2.1 splice variants during bursts of depolarization. In addition to tonic depolarizations, neurons experience various frequencies of burst firing in which brief periods of tonic firing are interspersed with silent periods as the membrane potential drops below threshold. [47] [48] [49] [50] [51] During the tonic firing periods P/Q-type channels will inactivate and during silent periods they will have the opportunity to recover from inactivation. Based upon the above noted splice-variant changes in accumulation of inactivation and recovery from inactivation, we predicted that bursts of depolarization would also differentially affect WT and FHM-1 mutated Ca V 2.1 (+47) and Ca V 2.1 (Δ47) variant channels. Figure 5 shows that WT Ca V 2.1 (+47) and Ca V 2.1 (Δ47) variants exhibit significant differences in the amount of current remaining at the end of five 25 Hz bursts given at 3.5 Hz. Current through the WT Ca V 2.1 (+47) variant decayed to 73 ± 3.4% by the end of the fifth burst while current through the WT Ca V 2.1 (Δ47) variant decayed to 88 ± 3.6% (p < 0.05; ANOVA) (Fig. 5C ). The increased inactivation during the depolarizations and the reduced recovery from inactivation of WT Ca V 2.1 (+47) variants discussed above likely contributed to the overall 15% decrease in current relative to the WT Ca V 2.1 (Δ47) variant. Figure 5 shows that during burst firing the K1336E mutation in the Ca V 2.1 (Δ47) variant background results in an overall lower percentage of current remaining at the end of five bursts (70 ± 4.9% vs. 88 ± 3.6%, respectively; p < 0.05; ANOVA) (Fig.  5C ), likely resulting from the increased accumulation of inactivation and slowed recovery from inactivation of K1336E Ca V 2.1 (Δ47) channels relative to WT Ca V 2.1 (Δ47) (see Figs. 3 and 4) . Contrastingly, the K1336E mutation in the Ca V 2.1 (+47) variant background did not show significant current decay relative to WT, likely due to the fact that although the K1336E Ca V 2.1 (+47) variant channels exhibit a small increase in accumulation of inactivation during tonic stimulation (Fig. 4) , they also possess an increased rate of recovery from inactivation (Fig. 3A) . We note that unlike WT channel variants, the K1336E Ca V 2.1 (+47) and K1336E Ca V 2.1 (Δ47) variants did not differ significantly relative to one another.
Similar to that for the K1336E mutation in the Δ47 background, examination of burst firing effects on the R192Q mutation showed an increase in current decay during burst firing relative to WT Ca V 2.1 (Δ47) channels (70 ± 3.6% vs. 88 ± 3.6% current remaining, respectively; p < 0.05; ANOVA) (Fig. 5C ). In contrast, the R192Q mutation in the +47 background resulted in a higher degree of current remaining compared to WT Ca V 2.1 (+47) channels (83 ± 2.7% vs. 73 ± 3.4% current remaining, respectively; 
(n = 5) S218L
Time constants were determined by fitting the average percent recovery with a double exponential for all constructs except the Ca V 2.1 (Δ47) K1336E which was best fit with a single exponential. Percent recovery is a measure of the percentage of current evoked during the test pulse, given at 7.5 seconds after the prepulse, relative to the maximum current evoked during the prepulse. Asterisks and number signs indicate significant difference between mutant and wild-type of the same variant with p-values less than either 0.05 or 0.001 (one-way ANOVA), respectively. Double asterisks indicate significant difference between the Ca V 2.1 Δ47 and +47 variants containing the same sequence (i.e. WT or mutant) with p-value less than 0.05 (one-way ANOVA). Number of cells recorded for each clone is indicated in parenthesis. N.A. = not applicable.
FHM-1 mutations exhibited a greater hyperpolarizing shift when expressed in the Ca V 2.1 (Δ47) variant compared to the Ca V 2.1 (+47) variant (Fig. 2) . In addition, we show for the first time that WT Ca V 2.1 (Δ47) and WT Ca V 2.1 (+47) variants have both different kinetics of recovery from inactivation and accumulation of inactivation during tonic depolarization that are likely relevant to the differential response of channel variants during bursts of depolarization (Figs. 3-5) . It is known that Figure 4 . Wild-type and FHM-1 mutant Ca V 2.1 (Δ47) and Ca V 2.1 (+47) variants exhibit different current decay during 25 Hz tonic depolarizations. (A) graphs show normalized current remaining vs. time after initial onset of depolarizations. Current decay was measured for wild-type (WT; black squares), FHM-1 mutant K1336E (KE; grey circles), R192Q (RQ; grey triangles) and S218L (SL; grey diamond) in both the short Ca V 2.1 (Δ47) (filled symbols) and long Ca V 2.1 (+47) (open symbols) C-terminus splice variants. (B) to investigate current decay during repetitive stimulations we used 25 square pulses from a holding of -100 mV to a depolarizing potential of -5 mV for a duration of 3.4 ms. The test pulses were given at a rate of 25 Hz. Representative current trace and pulse protocol indicated at bottom (capacitive transients were compensated using a P/4 protocol), with single current response enlarged. (C) bar graph shows the percent of current remaining at the end of 25 pulses for each clone. Single asterisks and number signs indicate significant difference between mutant and wild-type of the same variant with p-values less than either 0.05 or 0.001 (one-way ANOVA), respectively. Double asterisks indicate significant difference between the Δ47 and +47 variants containing the same sequence (i.e., WT or mutant) with p-value less than 0.05 (one-way ANOVA). Number of cells recorded for WT Ca V 2.1 (Δ47) (n = 14), WT Ca V 2.1 (+47) (n = 13), KE Ca V 2.1 (Δ47) (n = 15), KE Ca V 2.1 (+47) (n = 18), RQ Ca V 2.1 (Δ47) (n = 17), RQ Ca V 2.1 (+47) (n = 15), SL Ca V 2.1 (Δ47) (n =15), SL Ca V 2.1 (+47) (n = 14).
Ca V 2.1 channels in different states possess alternative modes of gating that are reflected in biophysical properties at the whole cell current level. 52, 53 Furthermore, it has been shown that alternative splicing in the EF-hand region of the Ca V 2.1 carboxyl terminus can shift gating modes. 54 It is therefore possible that WT Ca V 2.1 (Δ47) and WT Ca V 2.1 (+47) variants also have distinct gating modes that respond differently to FHM-1 mutations which are localized near voltage sensor regions (e.g., R192Q, S218L, P/Q-type splice variants and migraine Figure 5 . Wild-type and FHM-1 mutant Ca V 2.1 (Δ47) and Ca V 2.1 (+47) variants exhibit different current decay during bursts of depolarizations. (A) graphs show normalized current remaining vs. time after initial onset of depolarizations. Current decay was measured for wild-type (WT; black squares), FHM-1 mutant K1336E (KE; grey circles), R192Q (RQ; grey triangles) and S218L (SL; grey diamond) in both the short Ca V 2.1 (Δ47) (filled symbols) and long Ca V 2.1 (+47) (open symbols) C-terminus splice variants. (B) to investigate current decay during bursts of repetitive stimulations we used five bursts of 25 square pulses to -5 mV for 3.4 msec from a holding of -100 mV; bursts given at 290 msec intervals (3.5 Hz burst firing). Each burst contained 25 pulses at a rate of 25 Hz. Representative current trace indicated at bottom (capacitive transients were compensated using a P/4 protocol). (C) bar graph shows the percent of current remaining at the end of 6 seconds for each clone. Single asterisks and number signs indicate significant difference between mutant and wild-type of the same variant with p-values less than either 0.05 or 0.001 (one-way ANOVA), respectively. Double asterisks indicate significant difference between the Ca V 2.1 Δ47 and +47 variants containing the same sequence (i.e., WT or mutant) with p-value less than 0.05 (oneway ANOVA). Number of cells recorded for WT Ca V 2.1 (Δ47) (n = 8), WT Ca V 2.1 (+47) (n = 7), KE Ca V 2.1 (Δ47) (n = 8), KE Ca V 2.1 (+47) (n = 10), RQ Ca V 2.1 (Δ47) (n = 9), RQ Ca V 2.1 (+47) (n = 7), SL Ca V 2.1 (Δ47) (n =8), SL Ca V 2.1 (+47) (n = 8).
K1336E). Detailed single channel analyses would be required to fully explore this hypothesis.
Our findings provide the first suggestion for a potential role of P/Q-type channel alternative splicing in FHM-1 pathophysiology and raise the notion that even though Ca V 2.1 channels are widely expressed in the central and peripheral nervous systems, point mutations can have greater or lesser functional affects on specific splice variants. Although the mechanism of FHM-1 pathophysiology is not completely resolved, the current opinion is that the migraine usually initiates with aura due to CSD, which leads to headache pain through activation of the trigeminovascular pain pathway. 55, 56 In this regard, specific Ca V 2.1 variants within the cortex may have important roles in the onset of migraine attacks.
We show that the Ca V 2.1 (Δ47) and Ca V 2.1 (+47) variants are both expressed in whole human cortex (Fig. 1B) , and that the three FHM-1 mutations all cause a greater hyperpolarizing shift in the voltage-dependence of activation in Ca V 2.1 (Δ47) channels relative to that for Ca V 2.1 (+47) variant channels. A hyperpolarizing shift in P/Q-type channel activation has been suggested as an underlying mechanism of increased susceptibility to CSD and the initiation is likely to be important for interpreting results obtained in both heterologous and native systems, as well as for making inferences concerning disease mechanisms and phenotypes. Mutations in the Ca V 1.1 L-type channel are associated with hypokalemic periodic paralysis, the Ca V 1.2 L-type with Timothy syndrome, the Ca V 1.4 L-type with incomplete X-linked congenital stationary night blindness and X-linked cone-rod dystrophy, and the Ca V 3.2 T-type with idiopathic generalized epilepsy and autism spectrum disorder (reviewed in ref. 4 ). Similar to FHM-1, many of these disorders exhibit phenotypes with episodic and/or developmentally specific attributes localized to a subset of regions or tissues that express the respective channels, and like Ca V 2.1, these channels also undergo alternative splicing that generates functionally distinct channel variants (reviewed in refs. 6 and 7). The identification of specific Ca V splice variants involved in disease pathophysiology may also provide the opportunity for targeted therapeutic approaches. For example, while the Ca V 2.2 N-type channels have a central role in nociceptive signalling, distinct Ca V 2.2 splice variants are involved in the transmission of specific types of pain and has led to new strategies for splice variant-specific targeting in pain therapy. 60 
Methods
Site-directed mutagenesis. Standard PCR-based in vitro mutagenesis was performed using the Pfu Turbo DNA Polymerase (Stratagene, La Jolla, CA), 10 mM dNTPs (Invitrogen) and paired forward and reverse mutagenesis primers. 44 The human Ca V 2.1 long (+47) (isoform 2) (NCBI accession number NM_023035.1) cloned in pcDNA 3.1 Zeo (+) was used as the source for the generation of the WT short human Ca V 2.1 (Δ47) (isoform 1) cDNA (the other known six splice sites are: Δ10A, 16+/17+, -VEA, -NP, EFa, 43+/44+). Paired forward and reverse primers were designed to adhere to the C-terminus of the Ca V 2.1 isoform 2 at the exon 46/47 boundary nucleotide number 6784 and removed the GGCAG pentanucleotide sequence creating the premature stop in exon 47 (Ca v 2.1 (Δ47)). Both Ca V 2.1 splice variant cDNAs were used in site-directed mutagenesis reactions to generate human Ca V 2.1 K1336E, R192Q and S218L mutants in the short and long variants; paired forward and reverse primers were designed to convert codon 1336 from AAA to GAA, codon 192 from CGG to CAG, and codon 218 from TCG to TTA. The integrity of all constructs generated through site-directed mutagenesis were verified by direct DNA sequencing.
Cell culture and transfection. Human embryonic kidney (HEK 293) cells were grown in standard Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (heat inactivated) and 50 U/ml penicillin-50ug/ml streptomycin. Cells were incubated at 37°C in a humidified incubator with 95% atmosphere and 5% CO 2 and grown to 8-15% confluency for transfection. HEK 293 cells were transiently transfected with either WT human Ca V 2.1 (Δ47) or Ca V 2.1 (+47), or mutant K1336E Ca V 2.1 (Δ47), R192Q Ca V 2.1 (Δ47), S218L Ca V 2.1 (Δ47) or K1336E Ca V 2.1 (+47), R192Q Ca V 2.1 (+47), S218L Ca V 2.1 (+47) in combination with calcium channel auxiliary subunits β 4 , α 2 δ-1, and the CD8 marker plasmid in a 1:1:1:0.25 molar ratio using Lipofectamine (Invitrogen, La Jolla, CA). To ensure accurate of migraine. 22, 57 CSD begins within small domains of the cortex and propagates outward from a focal point. Our data supports the notion that Ca V 2.1 splice variants with greater sensitivity to hyperpolarizing shifts in the voltage-dependence of activation (e.g., Ca V 2.1 (Δ47), could result in cortical regions with greater susceptibility to CSD and migraine initiation. Conversely, the effects of FHM-1 mutations on other Ca V 2.1 splice variants (e.g., Ca V 2.1 (+47)), expressed elsewhere in the cortex or other brain regions may be below the threshold to initiate CSD and/or other pathological effects. Future exploration of the exact regional and cellular distributions of these and other Ca V 2.1 splice variants within the cortex and throughout the human brain using in situ hybridization and/ or RT-PCR analyses will be necessary to fully understand the role of Ca V 2.1 splice variants in FHM-1 pathology.
Our results examining tonic and burst firing patterns also suggests the possibility of differential effects of FHM-1 mutations on P/Q-type channel splice variants under different firing conditions. This is most clearly seen with the S218L mutation in the Ca V 2.1 (+47) variant; during tonic depolarization current decay is significantly faster relative to WT, yet during burst firing the S218L Ca V 2.1 (+47) variant has similar current decay to WT channels after five bursts, likely due to rapid recovery from inactivation (see Figs. 4 and 5) . On the other hand, in Ca V 2.1 (Δ47) variant channels the S218L mutation has significant effects on current decay under both tonic and burst firing conditions. Interestingly, certain initiating factors of FHM-1 attacks such as emotional stress 14 are known to alter neuronal firing patterns in the brain. 58, 59 Although the exact firing conditions directly associated with precipitating factors of migraine are unknown, the episodic nature of the FHM-1 phenotype may in part be associated with changes in neuronal firing pattern and/or frequency that could be relevant to specific Ca V 2.1 splice variants expressed in localized brain regions.
It is likely that there exists a complex relationship between channel missense mutations and disease mechanism. While we show alternative splicing at a single Ca V 2.1 splice-site can determine the functional impact of FHM-1 mutations, we recognize that across the entire brain many additional factors are likely to be involved in ultimately defining disease pathophysiology. These likely include the expression of multiple splice P/Q-type variants with distinct combinations of alternative splicing as well as the interaction with different auxiliary subunits 27 and other structural and regulatory proteins. Nonetheless, our results demonstrate the relevance of alternative splicing as an important factor in considering underlying disease molecular mechanisms and also the need for a comprehensive understanding of the splice-variant profile of Ca V 2.1 channels across brain regions and developmental stages as they might relate to FHM-1 pathology.
While in the present report we show that individual FHM-1 mutations can have differential effects on the biophysical properties of the short and long P/Q-type channel splice variants, we predict this phenomenon is likely relevant to both other FHM-1 mutations and Ca V 2.1 variants and also to other types of Ca V channels and calcium channelopathies. 61 Understanding the differential effects of channelopathy mutations on ion channel splice variants Boltzmann equation:
where A1 is minimum normalized current, A2 is the maximum normalized current, Vm is the test potential, V 50 is the half-inactivation potential, and k reflects the slope of the inactivation curve (goodness of fit had R 2 values ≥ 0.998).
The kinetics of activation (τ act ) were determined from currents obtained from the IV protocol. Current traces were fit with a standard single exponential equation: I = A*exp (-t/τ), where A is the amplitude of the current, and τ is the time constant.
Recovery from inactivation was determined using a doublepulse protocol. The first depolarization was to 0 mV for 2 s (the prepulse), followed by a return to the holding potential of -100 mV for variable lengths between 10 ms and 7.5 s. At the end of the variable repolarization period, a second 0 mV (the test pulse) was given for 50 ms. The time interval between sweeps was a total of 1 minute to ensure maximum recovery between sweeps. All traces were normalized to the maximum current during the prepulse for each sweep. The peak current from the test pulse was plotted as a percentage of maximum prepulse current vs. repolarization time. Average traces were fit with either a single or double exponential equation (goodness of fit had R 2 values ≥0.998).
Current decay during a tonic depolarization was examined using a 25 Hz train of 25 square pulses from a holding of -100 mV to a depolarizing potential of -5 mV for 3.4 ms. Current decay curves were generated by plotting normalized maximum current during the test pulses as a function of the time of pulse onset. Current decay during bursts of depolarization was examined using square pulses to -5 mV for 3.4 msec from a holding of -100 mV. Five bursts were given with 290 msec intervals (3.5 burst firing). Each burst contained 25 pulses at a rate of 25 Hz. Current decay curves were generated by plotting normalized maximum current during the test pulses as a function of the time of pulse onset.
RT-PCR of Ca V 2.1 carboxyl-terminal region from human cortex RNA. Prior to reverse transcription, 1 ug total RNA from human cortex (Clontech; 636561) was treated with 1X DNase I reaction buffer and 1 unit DNase I (Invitrogen) in a final volume adjusted to 10 uL using sterile DEPC-treated H 2 O. Following a 15-minute incubation period at room temperature, the reaction was inactivated by adding 1 uL of 25 mM EDTA and heating at 65°C for 10 minutes. cDNA synthesis was performed using Superscript II Reverse Transcriptase (Invitrogen) following manufacturer's instructions with slight modification. A ~1.1-Kb nucleotide fragment of the carboxyl end of the Ca V 2.1 channel was amplified from the human cortex cDNA using standard PCR. The reaction mixture consisted of 3% DMSO, 1X Phusion enzyme buffer, 0.4 pmol/uL of forward and reverse primers, 0.2 mM dNTPs, 1 uL of cortex cDNA, and 1 unit of Phusion enzyme in a final volume of 25 uL. The forward primer (5'GGC ACA TGG AGT CCG GAA CA 3') corresponds to nucleotide position 6130 and the reverse primer (5'GGT AGT AGC CAT GGT GCC3') to nucleotide position 7211 of the human Ca V 2.1 α 1 subunit (NCBI accession number NM_023035.1). The cycling profile included an initial activation step of 98°C for 30 s comparisons, transfections were performed at the same time and electrophysiological recordings alternated within the same day for all channel types.
Electrophysiological recordings. On the second day after transfection, macroscopic Ba 2+ currents where recorded at room temperature using the whole-cell patch-clamp technique. 45 The internal pipette solution used contained 105 mM CsCl, 25 mM TEACl, 1 mM CaCl 2 , 11 mM EGTA, 10 mM HEPES and 5 mM ATP (pH 7.2 with CsOH); external: 5 mM BaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, 40 mM TEACl, 10 mM glucose and 87.5 mM CsCl (pH 7.4 with TEAOH). Patch pipettes (borosilicate glass BF150-86-10; Sutter Instrument Company, Novato, CA) were made using a horizontal puller (P-87; Sutter Instruments Company) and fire polished using a microforge (Narishige, Tokyo, Japan), with resistances typically of 3 to 5 MΩ when containing internal solution. External solution bath was connected to ground with a 3 M KCl agar bridge. Whole cell currents were recorded and filtered at 2-5 kHz bandwidth using an Axopatch 200A amplifier monitored and stored on a personal computer running pClamp software package version 9. Sampling frequencies were between 2 and 10 kHz. Recordings were analyzed using Clampfit 9 and figures, fittings and statistics (ANOVA) were made using the software program Origin version 7.5 (OriginLab Corp., Northampton, MA). Data are represented as mean ± standard error (S.E.).
Recording protocols and data analysis. Current-voltage relationships were determined by measured currents obtained using a series of 90 millisecond depolarization pulses applied from a holding potential of -90 mV to membrane potentials from -50 mV to +45 mV, increasing by 5 mV increments. Current-voltage relationships were fitted, and IV curves generated, using a modified where Gmax is the maximum slope conductance, Vm is the test potential, E r is the extrapolated reversal potential, V 50 is the halfactivation potential, and k reflects the slope of the activation curve. Activation curves were constructed by calculating conductance from the IV curves and plotting the normalized conductance as a function of the membrane potential. The data were fit with the Boltzmann equation: G/Gmax = A2 + (A1 -A2)/(1 + exp((V m -V 50 )/k)) where A1 is minimum normalized conductance, A2 is maximum normalized conductance, V m is the test potential, V 50 is the halfactivation potential, and k reflects the slope of the activation curve (goodness of fit had R 2 values ≥ 0.998).
Voltage-dependence of inactivation was analyzed using depolarizations to 0 mV for 80 ms following 5 s prepulses ranging from -100 to +10 mV at 10mV increments (holding potential of -120 mV). Steady state inactivation curves were constructed by plotting the maximum normalized current during the test pulse as a function of the prepulse potential. The data were fit with the
